Pradimicin-IRD from Amycolatopsis sp. IRD-009 and its antimicrobial and cytotoxic activities

Nat Prod Res. 2019 Jun;33(12):1713-1720. doi: 10.1080/14786419.2018.1434639. Epub 2018 Feb 16.

Abstract

A new polycyclic antibiotic, pradimicin-IRD, was isolated from actinobacteria Amycolatopsis sp. IRD-009 recovered from soil of Brazilian rainforest undergoing restoration area. This molecule is the major compound produced in solid culture media. The new compound was detected by a focused method of precursor ion (high-performance liquid chromatography coupled to tandem mass spectrometer) developed previously to identify unusual aminoglycosyl sugar moieties. The compound was isolated and its structure was, therefore, elucidated by high-resolution mass spectrometry, and 1D and 2D nuclear magnetic resonance experiments. Pradimicin-IRD displayed potential antimicrobial activity against Streptococcus agalactiae (MIC 3.1 μg/mL), Pseudomonas aeruginosa (MIC 3.1 μg/mL) and Staphylococcus aureus (MIC 3.1 μg/mL), and also cytotoxicity against tumour and non-tumour cell lines with IC50 values ranging from 0.8 μM in HCT-116 colon carcinoma cells to 2.7 μM in MM 200 melanoma cells. Particularly, these biological properties are described for the first time for this chemical class.

Keywords: Actinobacteria; antibacterial activity; cytotoxic activity; natural products.

MeSH terms

  • Actinobacteria / chemistry*
  • Anthracyclines / chemistry
  • Anthracyclines / isolation & purification*
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / isolation & purification*
  • Brazil
  • Cell Line
  • Cell Line, Tumor
  • Chromatography, High Pressure Liquid
  • Humans
  • Inhibitory Concentration 50
  • Microbial Sensitivity Tests
  • Pseudomonas aeruginosa / drug effects
  • Soil Microbiology
  • Staphylococcus aureus / drug effects
  • Tandem Mass Spectrometry

Substances

  • Anthracyclines
  • Anti-Bacterial Agents